71. Metabolic, desmutagenic and anticarcinogenic effects ofN-acetylcysteine.De
Flora, Silvio, Rossi, G. A. and De Flora, A.Respiration 30(suppl. 1):43-9
(1986)
72. In vitro effects of N-acetylcysteine on the mutagenicity ofdirect-acting
compounds and procarcinogens.De Flora, Silvio, et al,Carcinogenesis 5(4):505-10
(1984)
73. In vivo effects of N-acetylcysteine on glutathionemetabolism and on
the biotransformation of carcinogenicand/or mutagenic compounds.De Flora,
Silvio, et alCarcinogenesis 6(12):1735-45 (1985)
74. Detoxification of genotoxic compounds as a thresholdmechanism limiting
their carcinogenicity.De Flora, S.Toxicol. Pathol. 12(4):337-43 (1984)
75. Effects of N-acetyl-L-cysteine and ascorbic acid onmutagen-induced chromosomal
sensitivity in patients withhead and neck cancers.Trazana, Zoltan, et al,Amer.
J. Surg. 162:294-8 (1991)
76. Effect of exogenous glutathione on tumor progression in themurine skin
multistage carcinogenesis model.Rotstein, J. B. and Slaga, T. J.
77. Second-line chemotherapy in small-cell lung cancer.Andersen, M., Kristjansen,
P. E. G. and Hansen, H. H.Cancer Treat. Rev. 17(4):427-36 (1990)
78. N-acetylcysteine as chemoprotectant in cancer chemotherapy.Martinez,
Esteban and Domingo, PereLancet 338:249 (July 27, 1991)
79. Long-term oral acetylcysteine in chronic bronchitis: Adouble-blind controlled
study.Multicenter Study GroupEur. J. Respir. Dis. 61(Sup.):93 (1980)
80. The reduction in vitro in viscosity of mucoproteinsolutions by a new
mucolytic agent, N-acetylcysteine.Sheffner, A. L.Ann. NY Acad. Sci. 106:288
(1963)
81. Toxicological, pharmacokinetics and metabolic studies onacetylcysteine.Bonanomi,
L. and Gazzaniga, A.Eur. J. Respir. Dis. 61(Sup):45-51 (1980)
82. AcetylcysteineMerck Index
83. Pharmokinetics of oral acetylcysteine.Rodenstein, D., DeCoster, A. and
Gazzaniga, A.Clin. Pharmacokin. 3:247-54 (1978)
84. Clinical pharmacokinetics of N-acetylcysteine.Borgstrom, L., Kagedal,
B. and Paulsen, O.Eur. J. Clin. Pharmacol. 31:217-22 (1986)
85. Pharmokinetics and bioavailability of reduced and oxidizedN-acetylcysteine.Olsson,
B., et al,Eur. J. Clin. Pharmocol. 34:77-82 (1988)
86. Acetylcysteine: A drug that is much more than a mucokinetic.Ziment,
I.Biomed. Pharmacother. 42:513-20 (1988)
87. Pharmacokinetics and bioavailability of oral acetylcysteinein healthy
volunteers.De Caro, L., et al,Arzneim.-Forsch/Drug Res., 39:382 (1989)
88. Clinical pharmacokinetics of N-acetylcysteine.Holdiness, M. R.Clin.
Pharmacokinet. 20:123-34 (1991)
All rights, including electronic and print media, to this article are copyrighted
by Richard A. Passwater, Ph.D. and Whole Foods magazine (WFC Inc.).